Jefferies LLC
-
Danish firm specialised in treatment for metabolic diseases issues 6.5m shares -
A book by Cazenove’s former CEO charts the build-up and aftermath of the deal that made JP Morgan a force in UK investment banking. But the financial crisis proved to be the real catalyst for its subsequent dominance
-
CureVac launched a capital increase following encouraging research results
-
Existing shareholders took a large chunk of the deal, 30% of bidders left empty-handed
-
Investment bank files for European direct lending fund
-
Investors rush to make the most of the pre-Thanksgiving window
-
-
Deal covered 0.52 times as bookbuilding moves to final leg
-
Life insurer backed by Bank of Baroda files draft papers with Sebi
-
The Swiss solar panel maker seeks to raise Sfr250m to expand production capacity
-
Real estate investment trust cancels plans to buy stores from Sainsbury's
-
Shareholders left empty-handed can curb dilution through repair issue
